The Valley Desk

NCT02523014 · Interventional trial

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Overall registry status Recruiting

Phase 2

Conditions Intracranial Meningioma, NF2 Gene Mutation, Recurrent Meningioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov